DEAD

Serial Number

97572549

Owner

Hememics Biotechnologies Inc

Attorney

Rachel Huffstetler

First Use Date

Mar 7, 2018

Filing Date

Aug 31, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

HEMEMICS BIOTECHNOLOGIES, INC. Trademark

Serial Number: 97572549

HEMEMICS BIOTECHNOLOGIES, INC. is a trademark filed by Hememics Biotechnologies Inc on August 31, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Hememics Biotechnologies Inc (6 trademarks)

401 Professional Dr, STE 220
Gaithersburg, MD 20879

Entity Type: 03

Legal Representation

Attorney of Record

Rachel Huffstetler

152 trademarks filed View all →

Correspondence Address

Rachel Huffstetler Pierson Ferdinand, LLP

4279 Roswell Rd.

Ste 208, No. 260

Atlanta, GA 30342

United States

Trademark Details

Filing Date

August 31, 2022

Registration Date

Not Registered

First Use Anywhere

March 7, 2018

First Use in Commerce

March 7, 2018

Published for Opposition

August 29, 2023

Goods & Services

Biosensor technology for rapid diagnostics of infectious agents in liquid samples, namely, medical diagnostic reagents and assays for rapidly diagnosing infectious diseases found in liquid samples

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Jan 13, 2025 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jan 13, 2025 ABN2

NOTIFICATION OF FINAL REFUSAL EMAILED

Sep 25, 2024 GNFN

FINAL REFUSAL E-MAILED

Sep 25, 2024 GNFR

SU - FINAL REFUSAL - WRITTEN

Sep 25, 2024 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 21, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 21, 2024 CRFA

ASSIGNED TO LIE

Aug 21, 2024 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 11, 2024 TROA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 17, 2024 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 17, 2024 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 17, 2024 REAP

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 12, 2023 GNRN

NON-FINAL ACTION E-MAILED

Dec 12, 2023 GNRT

SU - NON-FINAL ACTION - WRITTEN

Dec 12, 2023 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Nov 8, 2023 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 7, 2023 AITU

USE AMENDMENT FILED

Oct 25, 2023 IUAF

TEAS STATEMENT OF USE RECEIVED

Oct 25, 2023 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 24, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 29, 2023 NPUB

PUBLISHED FOR OPPOSITION

Aug 29, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 9, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 26, 2023 CNSA

EXAMINER'S AMENDMENT ENTERED

Jul 26, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 26, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Jul 26, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jul 26, 2023 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 5, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 5, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 5, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 26, 2023 GNRN

NON-FINAL ACTION E-MAILED

Jun 26, 2023 GNRT

NON-FINAL ACTION WRITTEN

Jun 26, 2023 CNRT

ASSIGNED TO EXAMINER

Jun 16, 2023 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Sep 20, 2022 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 19, 2022 NWOS

Related Trademarks

More from this Owner

HEMSOL

HEMBOX

REDEFINING RAPID

HEMCHIP

More in Same Class

NAL VON MINDEN DRUG-SCREEN

TMB PLUS2

PARA Q

NATIVE ROCK

BIBRIDGED